Alpine Peaks Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-110,518
Closed -$4.66M 23
2023
Q2
$4.66M Sell
110,518
-4,500
-4% -$182K 3.27% 16
2023
Q1
$4.1M Hold
115,018
3.09% 17
2022
Q4
$4.22M Buy
115,018
+17,275
+18% +$683K 3.42% 15
2022
Q3
$4.61M Buy
97,743
+42,790
+78% +$2.76M 4.14% 14
2022
Q2
$3.94M Buy
54,953
+8,000
+17% +$585K 4.6% 11
2022
Q1
$3.8M Buy
46,953
+6,000
+15% +$508K 3.91% 15
2021
Q4
$4.21M Buy
+40,953
New +$3.93M 4.12% 15

Other funds holding SYNH

Alpine Peaks Capital's SYNH Position: Q3 2023 in Review

Alpine Peaks Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 110,518 shares — an estimated $4.66M sold.

Alpine Peaks Capital first reported a position in SYNH in Q4 2021 and held it in 7 quarters. The position peaked at $4.66M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Alpine Peaks Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Alpine Peaks Capital sold 110,518 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.66M.
  • Alpine Peaks Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
  • Alpine Peaks Capital's Syneos Health, Inc. Class A Common Stock position peaked at $4.66M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Alpine Peaks Capital's 13F filing for Q3 2023, filed 14 Nov 2023.